1. 47 Completion of the clinical audit cycle for delivery of molecular testing service for patients with non-small-cell lung cancer referred to the Royal Marsden. (January 2016) Authors: Kordbacheh, T.; Kumar, R.; Biondo, A.; Tan, R.; Yap, T.; Popat, S.; Bhosle, J.; O'Brien, M.E. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A combination vertical inhibition approach with inhibitors of SHP2 and ERK provides improved activity in KRAS-mutant pancreatic and colorectal cancer models. (October 2022) Authors: Hindley, C.; Biondo, A.; Brothwood, J.; Dao, K.H.; Kandola, N.; Lyons, J.; Nakatsuru, Y.; Smyth, T.; Wagner, S.; Wallis, N.; Hearn, K. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combinatorial targets for the treatment of ovarian cancers with phosphatidylinositol-3-kinase inhibitors. (December 2016) Authors: Biondo, A.; Clarke, P.A.; Workman, P. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA. (23rd June 2022) Authors: Sims, M.; Ward, G.; Zhang, Z.; Jueliger, S.; Davis, M.; Boxall, A.; Taylor, J.; Biondo, A.; Lyons, J.; Smyth, T. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗